Ghosh, B., Antonio, T., Zhen, J., Kharkar, P., Reith, M. E. A., & Dutta, A. K. (2010). Development of (S)-N(6)-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: Potent in vivo activity in Parkinson’s disease animal models.

Ghosh, Balaram, Tamara Antonio, Juan Zhen, Prashant Kharkar, Maarten E. A. Reith, and Aloke K. Dutta. Development of (S)-N(6)-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and Its Analogue As a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models. 2010.

Ghosh, Balaram, et al. Development of (S)-N(6)-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and Its Analogue As a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models. 2010.